Could a nerve pain drug soothe IBS symptoms?
NCT ID NCT07635394
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether pregabalin, a drug used for nerve pain, can ease symptoms of irritable bowel syndrome (IBS). About 258 adults with mild-to-moderate IBS will receive either pregabalin or standard IBS treatments for 12 weeks. Researchers will measure changes in IBS severity and quality of life.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- pregabalin
- What this could lead to
- If it works, this could offer a new option to reduce IBS pain and improve quality of life.
- What could go wrong
- This is an early-stage trial with no phase designation, so results may not confirm benefit. Pregabalin can cause dizziness, drowsiness, and other side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IRRITABLE BOWEL SYNDROME (IBS) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Beijing Tiantan Hospital
RECRUITINGBeijing, Beijing Municipality, 100050, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a Dual-Action supplement tame irritable bowel syndrome?
- Could an Anti-Inflammatory diet designed for Crohn's disease also tame IBS?
- Scientists hunt for the exact FODMAPs that trigger IBS pain
- Gut-Brain connection in IBS: scientists hunt for clues to anxiety and depression
- Massive new registry aims to crack the code on mysterious gut disorders
- Gut check: 4,000-Person study links diet, genes, and stomach troubles